Oliver Lagore Vanvalin Investment Group Moderna, Inc. Transaction History
Oliver Lagore Vanvalin Investment Group
- $359 Million
- Q3 2024
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Moderna, Inc. stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 764 shares of MRNA stock, worth $30,093. This represents 0.01% of its overall portfolio holdings.
Number of Shares
764
Previous 1,114
31.42%
Holding current value
$30,093
Previous $132,000
61.36%
% of portfolio
0.01%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding MRNA
# of Institutions
953Shares Held
240MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.67 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.58 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.01 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$664 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$285 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $15.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...